330 related articles for article (PubMed ID: 25560432)
1. Current status of viral expression systems in plants and perspectives for oral vaccines development.
Salazar-González JA; Bañuelos-Hernández B; Rosales-Mendoza S
Plant Mol Biol; 2015 Feb; 87(3):203-17. PubMed ID: 25560432
[TBL] [Abstract][Full Text] [Related]
2. Virus-like particles produced in plants as potential vaccines.
Scotti N; Rybicki EP
Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411
[TBL] [Abstract][Full Text] [Related]
3. The green revolution: plants as heterologous expression vectors.
Koprowski H; Yusibov V
Vaccine; 2001 Mar; 19(17-19):2735-41. PubMed ID: 11257417
[TBL] [Abstract][Full Text] [Related]
4. Transgenic plants as vaccine production systems.
Mason HS; Arntzen CJ
Trends Biotechnol; 1995 Sep; 13(9):388-92. PubMed ID: 7546570
[TBL] [Abstract][Full Text] [Related]
5. Use of viral vectors for vaccine production in plants.
Cañizares MC; Nicholson L; Lomonossoff GP
Immunol Cell Biol; 2005 Jun; 83(3):263-70. PubMed ID: 15877604
[TBL] [Abstract][Full Text] [Related]
6. The potential of plant viral vectors and transgenic plants for subunit vaccine production.
Awram P; Gardner RC; Forster RL; Bellamy AR
Adv Virus Res; 2002; 58():81-124. PubMed ID: 12205784
[No Abstract] [Full Text] [Related]
7. Current status of plant-made vaccines for veterinary purposes.
Ling HY; Pelosi A; Walmsley AM
Expert Rev Vaccines; 2010 Aug; 9(8):971-82. PubMed ID: 20673018
[TBL] [Abstract][Full Text] [Related]
8. Magnifection--a new platform for expressing recombinant vaccines in plants.
Gleba Y; Klimyuk V; Marillonnet S
Vaccine; 2005 Mar; 23(17-18):2042-8. PubMed ID: 15755568
[TBL] [Abstract][Full Text] [Related]
9. Plant cell factories and mucosal vaccines.
Walmsley AM; Arntzen CJ
Curr Opin Biotechnol; 2003 Apr; 14(2):145-50. PubMed ID: 12732315
[TBL] [Abstract][Full Text] [Related]
10. The potential of plant virus vectors for vaccine production.
Yusibov V; Rabindran S; Commandeur U; Twyman RM; Fischer R
Drugs R D; 2006; 7(4):203-17. PubMed ID: 16784246
[TBL] [Abstract][Full Text] [Related]
11. Transgenic plants for the production of veterinary vaccines.
Dus Santos MJ; Wigdorovitz A
Immunol Cell Biol; 2005 Jun; 83(3):229-38. PubMed ID: 15877600
[TBL] [Abstract][Full Text] [Related]
12. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.
Hemmati F; Hemmati-Dinarvand M; Karimzade M; Rutkowska D; Eskandari MH; Khanizadeh S; Afsharifar A
Biotechnol Lett; 2022 Jan; 44(1):45-57. PubMed ID: 34837582
[TBL] [Abstract][Full Text] [Related]
13. Transient expression systems for plant-derived biopharmaceuticals.
Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
[TBL] [Abstract][Full Text] [Related]
14. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for plant-made vaccines in the prevention of HIV/AIDS?
Webster DE; Thomas MC; Pickering R; Whyte A; Dry IB; Gorry PR; Wesselingh SL
Immunol Cell Biol; 2005 Jun; 83(3):239-47. PubMed ID: 15877601
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy to generate virus vaccines with expanded genetic codes.
Guo D
Sci China Life Sci; 2017 May; 60(5):555-557. PubMed ID: 28299577
[No Abstract] [Full Text] [Related]
17. Plant-produced vaccines: promise and reality.
Rybicki EP
Drug Discov Today; 2009 Jan; 14(1-2):16-24. PubMed ID: 18983932
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus expression vector system for production of viral vaccines.
Vlak JM; Keus RJ
Adv Biotechnol Processes; 1990; 14():91-128. PubMed ID: 2222839
[No Abstract] [Full Text] [Related]
19. Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.
Narayanan KB; Han SS
Virus Genes; 2018 Oct; 54(5):623-637. PubMed ID: 30008053
[TBL] [Abstract][Full Text] [Related]
20. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.
Tang N; Zhang Y; Shen Z; Yao Y; Nair V
CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
